Advances in Tumour Biomarkers for Screening, Diagnosis and Management of Ovarian MalignanciesCorrespondence Address :
Dr. Naina Kumar,
House Number-2, F-Block, Maharishi Markandeshwar Institute of Medical Sciences and Research Campus, Mullana, Ambala-133207, Haryana, India.
Ovarian cancer is one of most deadly malignancies in women, accounting for 1,52,000 deaths annually worldwide. Most ovarian malignancies are diagnosed at advanced stages when they have already metastasised to distant sites. Many researches are still under way to find means of detecting this malignancy at an early stage, so as to improve overall survival rates associated with it. One such way is use of serum biomarkers, which can help to some extent in detecting these cancers at an early stage as well as to follow-up patients during chemotherapy, after surgery and for detection of recurrent/persistent disease. Present review throws light on some of these novel biomarkers that help in detection and follow-up of women with ovarian cancers.
Antibodies, Cancer, Chemotherapy
Date of Submission: Nov 21, 2017
Date of Peer Review: Jan 18, 2018
Date of Acceptance: Feb 06, 2018
Date of Publishing: Apr 01, 2018
FINANCIAL OR OTHER COMPETING INTERESTS: None.
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2017: 134.54
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)